posted on 1997-08-19, 00:00authored byDuncan H. Purvis, Bridget C. Mabbutt
Leukemia inhibitory factor (LIF) is a hematopoietic cytokine which
elicits its effects on diverse
cell types via both gp130 and a more specific LIF receptor.
Recombinant murine LIF was studied by
multidimensional homonuclear and 1H−15N
heteronuclear NMR and 95% of backbone amide resonances
assigned. Definition of the secondary structure by chemical shift
data and NOE connectivities shows a
four-α-helix bundle fold (helices A−D) in solution, with an
additional flexible turn of helix in the AB
loop. Subtle differences are seen in the conformations of helices
A and D from those defined in the
crystal structure [Robinson, R. C., Grey, L. M., Staunton, D.,
Vankelcom, H., Vernallis, A. B., Moreau,
J.-F., Stuart, D. I., Heath, J. K., & Jones, E. Y. (1994) Cell
77, 1101−1116]. The dynamics of
the
polypeptide backbone of LIF were assessed from 15N
T1 and T2 relaxation
times and 15N−1H heteronuclear
NOEs of the amide groups. Using model-free formalism, the overall
rotational correlation time of LIF
in solution is calculated to be 9.7 ps. The four α-helices are
relatively rigid, and high mobility is observed
for N-terminal residues (Ser 1−Asn 21) and the AB loop. In
contrast to several closely related cytokines,
the long CD loop is relatively rigid. This may have implications
for interactions with the specific LIF
receptor, which binds in this region.